Pharma Pulse 2/25/25: Social Media Influence on Young Women's Reproductive Decisions, Molecular COVID/Flu Multiplex Test Granted FDA Emergency Use & more

Social Media's Influence on Young Women's Reproductive Decisions

In this Q&A, Organon's Chief Communications Officer, Becky Edwards discusses how much social media and influencers sway decisions about birth control methods, potential consequences of these misinformed choices, and more.

Molecular COVID/Flu Multiplex Test is Granted FDA Emergency Use Authorization

The test results are available in as little as 20 minutes.

Emerging Stocks Plunge on Trump’s Latest Moves Against China

Emerging-market stocks plunged Monday, falling the most in over three weeks, as US President Donald Trump’s latest executive order targeting China stirred up a new round of risk aversion.

IQVIA AI Assistant wins 2024 PM360 Innovation Award for Artificial Intelligence

IQVIA announced that IQVIA AI Assistant has been awarded a 2024 PM360 Innovation Award in the Artificial Intelligence category.

Launched in September 2024, IQVIA AI Assistant revolutionizes insight generation by providing rapid, relevant and precise answers to complex business questions. Using a conversational interface with advanced data science, it makes complex analytics accessible to a wide variety of users and provides near real-time insights.

Nicholas Saraceno on LinkedIn

Thanks for the chat,Tom. We discuss all things #polypharmacy - the use of five or more medications by an individual - including how it's becoming an increasingly prominent issue in the United States.

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs